| Date | Time | Source | Headline | Symbol | Company |
| 07/12/2018 | 09:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 07/12/2018 | 08:18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 05/12/2018 | 09:53 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 05/12/2018 | 09:49 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 14/11/2018 | 09:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 14/11/2018 | 09:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 14/11/2018 | 09:00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 14/11/2018 | 08:59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 10/11/2018 | 09:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 10/11/2018 | 08:19 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 10/11/2018 | 08:17 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 31/10/2018 | 07:32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 27/10/2018 | 07:59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 27/10/2018 | 07:18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 25/10/2018 | 08:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 25/10/2018 | 08:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 03/10/2018 | 06:57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 26/09/2018 | 07:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 26/09/2018 | 07:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 26/09/2018 | 07:00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 26/09/2018 | 06:59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 25/09/2018 | 06:20 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 19/09/2018 | 06:57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 05/09/2018 | 06:46 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 17/08/2018 | 21:01 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 15/08/2018 | 07:06 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 15/08/2018 | 07:00 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 08/08/2018 | 07:04 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 04/08/2018 | 07:22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 04/08/2018 | 06:18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |